The Senate approved the Fiscal Year 2025 National Defense Authorization Act (FY25 NDAA) on December 18, 2024. The bill is now on its way to ...

n a bid to enhance transparency and support data-driven ... for research and evidence-based policy-making in the JKN program.

Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation ADCs. Its drug platform technology, known as Engineered Toxin Bodies (ETBs ...

Molecular Templates (MTEM) was notified on December 16 by the Listing Qualifications Department of The Nasdaq Stock Market of the Staff’s ...